Luminary Therapeutics

Minneapolis, MN · Founded 2019 · Privately Held (backing)

Developer a cell therapy platform designed for cancer and autoimmune diseases. Luminary Therapeutics is based in Minneapolis, MN and was founded in 2019. Its last reported valuation was $59 million in Apr 2025. It has raised $24.2 million across 6 recorded rounds; the latest was a $1.4 million seed round in Oct 2025.

Last reported valuation
$59.0M
Oct 2026
Priced at
—
Total raised
$24.2M
Last round
Seed Round
Oct 2025

Who backs Luminary Therapeutics?

7 investors
InvestorType
National Institutes of HealthOther
Lateral Capital ManagementVenture capital
Cure Xchange ChallengeOther
701 Fund—
Cure Experience Services—
Lunch Pail Ventures—
ScaleReady—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Luminary Therapeutics investors

7 investors are on record for Luminary Therapeutics, including National Institutes of Health, Lateral Capital Management, Cure Xchange Challenge and 701 Fund. The seed round in Oct 2025 drew 6 investors.

Free account
More of Luminary Therapeutics with a free account
  • ·Watch Luminary Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Luminary Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View